GDDIF is designed with an interactive and engaging format, where influential leaders from around the world and across all the relevant areas, meet to debate. Globally 80 % of the persons came from European countries and more than 50% have key positions in Big and Midsize Pharma.
For our first participation to this scientific event we organized a lottery; it was a funny way to meet the delegates to better understand their needs!
This game was based on different questions referring to the or...
GDDIF Congress: Global Discovery to Development Innovation Leaders Summit 7th & 8th March 2011.
You have several reasons to come and visit us during GDDIF Congress (7th & 8th of March) in London:
- new strategies on preclinical development and discovery will be discussed.
- to assist to a conference on " In vivo models to select your leads " performed by Vincent Girod, Head of In vivo pharmacology in Syncrosome the 7th of March at 11:15 on the main room. Relevance of in v...
Syncrosome is a Preclinical Drug Evaluation Company specialised in human and animal health in vivo pharmacological studies. Syncrosome has the professional expertise to complete studies independently or to work in parallel with in-house research teams, after preliminary in vitro screenings - www.syncrosome.com